PD-1, PD-L1, and B7-H3 expression in Human Immunodeficiency Virus (HIV) infected patients with aerodigestive (AD) cancers (CA).

被引：1
|
作者：
Scilla, Katherine Ann
Heath, Jonathon
Ioffe, Olga B.
Cellini, Ashley L.
Edelman, Martin J.
Zandberg, Dan Paul
Riedel, David
Feliciano, Josephine Louella
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Dept Pathol, Baltimore, MD 21201 USA
[3] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[6] Univ Maryland, Med Ctr, Inst Human Virol, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11607
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer
    Mahmoud, Ahmed M.
    Frank, Igor
    Orme, Jacob J.
    Lavoie, Roxane R.
    Thapa, Prabin
    Costello, Brian A.
    Cheville, John C.
    Gupta, Sounak
    Dong, Haidong
    Lucien, Fabrice
    BMC UROLOGY, 2022, 22 (01)
  • [22] B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer
    Zhang, Wei
    Acuna-Villaorduna, Ana
    Kuan, Kevin
    Gupta, Sorab
    Hu, Shaomin
    Ohaegbulam, Kim
    Albanese, Joseph
    Kaumaya, Meghan
    Levy, Rachel
    Hwang, Richard R.
    Zang, Xingxing
    Lin, Juan
    Liu, Qiang
    Maitra, Radhashree
    Goel, Sanjay
    CLINICAL COLORECTAL CANCER, 2021, 20 (02) : 161 - 169
  • [23] Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response
    Sznol, Mario
    Chen, Lieping
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5542 - 5542
  • [24] Investigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients With Psoriasis
    Emre, Selma
    Sungu, Nuran
    Hayran, Yildiz
    Demirseren, Deniz
    Aktas, Akin
    Duman, Tuce Ozkara
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (02):
  • [25] Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Letter
    Radvanyi, Laszlo
    Pilon-Thomas, Shari
    Peng, Weiyi
    Sarnaik, Amod
    Mule, James J.
    Weber, Jeffrey
    Hwu, Patrick
    CLINICAL CANCER RESEARCH, 2013, 19 (19) : 5541 - 5541
  • [26] PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia
    Zong, Liju
    Zhang, Ming
    Wang, Wenze
    Wan, Xirun
    Yang, Junjun
    Xiang, Yang
    HISTOPATHOLOGY, 2019, 75 (03) : 421 - 430
  • [27] Genomic lesions and PD-1/PD-L1 expression in resected triple negative breast cancers
    Barrett, Michael T.
    Lenkiewicz, Elizabeth
    Malasi, Smriti
    Yearley, Jennifer H.
    Annamalai, Lakshmanan
    McCullough, Ann E.
    Anderson, Karen S.
    Pockaj, Barbara A.
    CANCER RESEARCH, 2018, 78 (04)
  • [28] Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity
    Xu, Yao
    Xiao, Yang
    Luo, Cheng
    Liu, Qingxia
    Wei, Aiqi
    Yang, Yang
    Zhao, Liwen
    Wang, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [29] The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
    Tang, Qing
    Chen, Yun
    Li, Xiaojuan
    Long, Shunqin
    Shi, Yao
    Yu, Yaya
    Wu, Wanyin
    Han, Ling
    Wang, Sumei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1
    Ishibashi, Mariko
    Tamura, Hideto
    Sunakawa, Mika
    Kondo-Onodera, Asaka
    Okuyama, Namiko
    Hamada, Yasuko
    Moriya, Keiichi
    Choi, Inhak
    Tamada, Koji
    Inokuchi, Koiti
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 779 - 788
12345